24 May 2013
Keywords: ziopharm, granted, orphan, status, sts, treatment, usa-based
Article | 19 May 2008
USA-based Ziopharm Oncology has received Orphan Drug status for its palifosfamide injection for the treatment of soft tissue sarcomas from
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 May 2008
23 May 2013
© 2013 thepharmaletter.com